HC Systems, LLC

HC Systems, LLC was paid $269K by Medicaid between Jul 2020 and Dec 2023, across 19 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 28% of everything it billed.

33Billing provider infoHC SYSTEMS, LLC
LEXINGTON, KY 40503

33aNPI1659927333assigned 08/17/2019

33bProvider typeClinical Medical Laboratory

28Total paid$269K

24GClaims14,734

24DCodes billed19

24AFirst – last monthJul 2020 – Dec 2023

Compared with peers

Next to other Clinical Medical Laboratory providers in Kentucky

Rank by total paid#30 of 73

Median peer was paid$95K

This provider vs. median2.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	364	$14K
2021	1,689	$39K
2022	9,693	$173K
2023	2,988	$42K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	28%	2,275	1,698	$75K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	16%	1,068	823	$43K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	13%	1,129	809	$35K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	11%	2,828	1,979	$30K
87150		10%	971	765	$28K
87631		8.3%	336	274	$22K
87500		3.5%	980	772	$10K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	1.8%	333	297	$5K
87653		1.4%	995	774	$4K
87481		1.3%	980	772	$4K
87641		1.3%	983	772	$3K
87640		<1%	981	773	$2K

7 more codes

87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	17	$1K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	132	$1K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	49	$1K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	212	$1K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	212	$1K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	210	$951.39
81003		<1%	43	$21.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPAYNE, COLEMAN (MANAGING PARTNER)